Do Investors Have A Better Shot With BioNTech Or Moderna?

Ashley Hayes

Published on: 02/08/2021

While there may be little difference between the COVID-19 vaccines developed by BioNTech and Moderna, there are some significant differences between the two

BioNTechBiotech StocksCOVID VaccineCOVID-19InvestingInvestorsModernaStock MarketBiotech StocksCoronavirusCOVID-19 PandemicInvestInvestingInvestment StrategiesInvestors

The Best Biotech To Buy And Hold

Ashley Hayes

Published on: 17/05/2021

When it comes to the best long-term hold in biotech, this company could be the one – and its efforts related to infectious diseases, including COVID-19, is

Best Biotech InvestmentsBiotech SectorCOVID-19Long-Term HoldModernaModerna InvestmentsStock Market2021 Stock PicksBuy-and-Hold InvestingCoronavirusCoronavirus PandemicCOVID-19 PandemicHealth StocksInvestors

The Big Names, Smaller Newcomers, And Emerging Market Players In The Race For A COVID Cure

Ashley Hayes

Published on: 31/08/2020

From prominent names such as Moderna to smaller newcomers such as Tyme Technologies to emerging market players such as Indian biotech Cipla, here are some of

Biotech InvestingBiotech InvestmentsBiotech StocksCOVID CureCOVID-19ModernaTyme TechnologiesVaccine Race2020 Stock PicksBiotech InvestmentsBiotech StocksCoronavirusCoronavirus PandemicCOVID-19 PandemicStock Market